Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China

International Journal of Cancer

Volumn 115, Issue 4, 2005, Pages 618-624

  Sakoda, Lori C ^a   Graubard, Barry I ^a   Evans, Alison A ^b   London, W Thomas ^b   Lin, Wen Yao ^c   Shen, Fu Min ^d   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c Haimen Center for Disease Control   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Epidemiology; Liver; Neoplasm; Selenium

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; SELENIUM; TRACE ELEMENT;

ADULT; ALCOHOL CONSUMPTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MORTALITY; CANCER RISK; CHINA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FLAME PHOTOMETRY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAIL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; STATISTICAL ANALYSIS; VIRUS HEPATITIS;

ADULT; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HEPATITIS; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NAILS; OCCUPATIONS; SELENIUM; SEX CHARACTERISTICS; SMOKING; URBAN POPULATION;

EID: 18544365976     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20937     Document Type: Article

References (42)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001;37(Suppl 8):S4-66.
2. Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, Gladyshev VN, Hatfield DL. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 2004;279:8011-7.
3. Corrocher R, Casaril M, Bellisola G, Gabrielli G, Hulpe M, Garofoli E, Nicoli N. Reduction of liver glutathione peroxidase activity and deficiency of serum selenium in patients with hepatocellular carcinoma. Tumori 1986;72:617-9.
4. Yu SY, Chu YJ, Li WG. Selenium chemoprevention of liver cancer in animals and possible human applications. Biol Trace Elem Res 1988;15:231-41.
5. Chen J, Geissler C, Parpia B, Li J, Campbell TC. Antioxidant status and cancer mortality in China. Int J Epidemiol 1992;21:625-35.
6. Hsing AW, Guo W, Chen J, Li JY, Stone BJ, Blot WJ, Fraumeni JF Jr. Correlates of liver cancer mortality in China. Int J Epidemiol 1991;20:54-9.
7. Yu SY, Li WG, Zhu YJ, Yu WP, Hou C. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Elem Res 1989;20:15-22.
8. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 1991;29:289-94.
9. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 1997;56:117-24.
10. Yu MW, Homg IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 1999;150:367-74.
11. Longnecker MP, Stampfer MJ, Morris JS, Spate V, Baskett C, Mason M, Willett WC. A l-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 1993;57:408-13.
12. London WT, Evans AA, McGlynn K, Buetow K, An P, Gao L, Lustbader E, Ross E, Chen G, Shen F. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995;38:155-61.
13. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Chronic HBV infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol 2005; DOI: 10.1093/ije/dyh339.
14. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90, 000-person Haimen City cohort: I, hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002;11:369-76.
15. Association of Official Analytic Chemists. Official methods of analysis of the AOAC, 15th ed. Arlington, MA: Association of Official Analytic Chemists, 1990.
16. London WT, McGlynn KA. Liver cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996.772-93.
17. Robberecht H, Deelstra H. Factors influencing blood selenium concentration values: a literature review. J Trace Elem Electrolytes Health Dis 1994;8:129-43.
18. Kafai MR, Ganji V. Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 2003;17:13-8.
19. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers Prev 1993;2:107-12.
20. Lu J. Apoptosis and angiogenesis in cancer prevention by selenium. Adv Exp Med Biol 2001;492:131-45.
21. Raich PC, Lu J, Thompson HJ, Combs GF Jr. Selenium in cancer prevention: clinical issues and implications. Cancer Invest 2001;19:540-53.
22. Schrauzer GN. Anticarcinogenic effects of selenium. Cell Mol Life Sci 2000;57:1864-73.
23. Vinceti M, Rovesti S, Bergomi M, Vivoli G. The epidemiology of selenium and human cancer. Tumori 2000;86:105-18.
24. Kalkan A, Bulut V, Avci S, Celik I, Bingol NK. Trace elements in viral hepatitis. J Trace Elem Med Biol 2002;16:227-30.
25. Loguercio C, De Girolamo V, Federico A, Feng SL, Cataldi V, Del Vecchio BC, Gialanella G. Trace elements and chronic liver diseases. J Trace Elem Med Biol 1997;11:158-61.
26. Navarro-Alarcon M, Lopez-Ga de la Serrana, Perez-Valero V, Lopez-Martinez MC. Selenium concentrations in serum of individuals with liver diseases (cirrhosis or hepatitis): relationship with some nutritional and biochemical markers. Sci Total Environ 2002;291:135-41.
27. Irmak MB, Ince G, Ozturk M, Cetin-Atalay R. Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Res 2003;63:6707-15.
28. Zhang W, Cox AG, Taylor EW. Hepatitis C virus encodes a selenium-dependent glutathione peroxidase gene: implications for oxidative stress as a risk factor in progression to hepatocellular carcinoma. Med Klin (Munich) 1999;94(Suppl 3):2-6.
29. Kocyigit A, Erel O, Gur S. Effects of tobacco smoking on plasma selenium, zinc, copper and iron concentrations and related antioxidative enzyme activities. Clin Biochem 2001;34:629-33.
30. Korpela H, Kumpulainen J, Luoma PV, Arranto AJ, Sotaniemi EA. Decreased serum selenium in alcoholics as related to liver structure and function. Am J Clin Nutr 1985;42:147-51.
31. Waters DJ, Chiang EC, Cooley DM, Morris JS. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 2004;551:91-107.
32. Pinto RE, Bartley W. The nature of the sex-linked differences in glutathione peroxidase activity and aerobic oxidation of glutathione in male and female rat liver. Biochem J 1969;115:449-56.
33. Pinto RE, Hartley W. The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 1969;112:109-15.
34. Capel ID, Smallwood AE. Sex differences in the glutathione peroxidase activity of various tissues of the rat. Res Commun Chem Pathol Pharmacol 1983;40:367-78.
35. Igarashi T, Satoh T, Ono S, Iwashita K, Hosokawa M, Ueno K, Kitagawa H. Effect of steroidal sex hormones on the sex-related differences in the hepatic activities of gamma-glutamyltranspeptidase, glutathione S-transferase and glutathione peroxidase in rats. Res Commun Chem Pathol Pharmacol 1984;45:225-32.
36. Massafra C, Gioia D, De Felice C, Picciolini E, De Leo V, Bonifazi M, Bemabei A. Effects of estrogens and androgens on erythrocyte antioxidant Superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol 2000;167:447-52.
37. Smith AM, Chang MP, Medeiros LC. Generational differences in selenium status of women. Biol Trace Elem Res 2000;75:157-65.
38. Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R. Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol 2001;15:298-303.
39. Ha EJ, Smith AM. Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. J Am Coll Nutr 2003;22:43-51.
40. Klein EA. Selenium: epidemiology and basic science. J Urol 2004;171:850-3.
41. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, Chem HD, Liaw YF, Chen CJ. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999;149:621-9.
42. Yu MW, Hsieh HH, Pan WH, Yang CS, Chen CJ. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res 1995;55:1301-5.